Stratafix Vs. Vicryl OAGB / MGB Suture Study

December 12, 2024 updated by: Andreas Plamper, St. Franziskus Hospital

Comparison of 2 Suture Materials for Closure of Ventral Defect At the Gastrojejunostomy in One-Anastomosis-Gastric Bypass / Mini-Gastric Bypass (OAGB / MGB): a Randomized Short Term Study with Monocrylic Spiral Knotless Tissue Control Device Vs. Traditional Polyglactin Multifilament Suture

To compare shorttime (6 months) results of two competitive suture materials with regard to time demanded to perform the concerned surgical step and secondary to study anastomotic site safety and complications like leakage and hemorrhage as well as development of anastomotic strictures. Evaluation of cost-effectiveness.

Study Overview

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cologne, Germany, 50825
        • St. Franziskus-Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • adult patients selected for primary Mini-Gastric bypass to treat obesity (BMI>30)
  • laparoscopic access feasable (intention to treat laparoscopically)
  • failed conservative treatment (accepted by health insurance companies)
  • relevant co-morbidities in cases with BMI <40
  • age 18 years or elder

Exclusion Criteria:

  • severe language problems
  • revisional or redo-procedures
  • operation intended as open procedure(extensive previous surgeries),
  • operation performed under corticoid-medication
  • operation performed under full-dose anticoagulants
  • operation performed by another surgeon than one of the 3 experienced MGB-surgeons of the Department

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Vicryl
Closure of ventral defect of the otherwise stapled gastrojejunal anastomosis with Vicryl USP 2-0 thread
Other Names:
  • traditional polyglactin multifilament suture
Experimental: Stratafix
Closure of ventral defect of the otherwise stapled gastrojejunal anastomosis with Stratafix USP (United States Pharmacopoe) 2-0 thread
Other Names:
  • monocrylic spiral knotless tissue control device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Closure of gastrojejunostomy
Time Frame: The assessment of this surgical step will be completed during the operation.
time needed to perform this specific surgical step, i.e. the ventral defect closure of the (otherwise stapled) gastrojejunostomy
The assessment of this surgical step will be completed during the operation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anastomotic site perioperative morbidity
Time Frame: 6 months
Number of participants with hemorrhage, leakage or symptomatic strictures requiring further diagnostic or therapeutic measurements
6 months
other anastomosis- related morbidity
Time Frame: 6 months
Number of participants with marginal ulcer or anastomotic stricture needing further diagnostic and/or interventions
6 months
economical factors
Time Frame: 6 months
costs of treatment in case the above mentioned complications occur and require intervention
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 6, 2020

Primary Completion (Actual)

October 27, 2023

Study Completion (Actual)

April 30, 2024

Study Registration Dates

First Submitted

October 21, 2020

First Submitted That Met QC Criteria

November 2, 2020

First Posted (Actual)

November 3, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 12, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anastomotic Leak

Clinical Trials on Stratafix

Subscribe